Nektar Therapeutics | NKTR - EPS每股收益



金融业
股票价格
USD
资产
USD 763.27M
现金及等价物
USD 149.58M
销售成本
USD 4.44M
流动资产
USD 589.04M
流动负债
USD 57.71M
债务
USD 0
股息收益率
0
EBIT
USD -38.26M
EBITDA
USD -38.9M
员工
137
EPS每股收益
USD -1.78
股本和储备
USD 576.22M
销售毛利
USD 10.86M
债务利息支出
USD 7.94M
利息收入
USD -0.18
贷款资金
USD 60.27M
市值
USD 13.62B
净收入
USD -44.9M
营业费用
USD 49.12M
营业利润
USD -38.26M
普通股股本
USD 29.47M
税前利润
USD -43.09M
销售收入
USD 10.86M
销售和管理费用
USD 11.87M
股票
USD 14.46M
贸易债权人
USD 10.03M
应收帐款人
USD 3.6M


Eps 更改 日
Agios Pharmaceuticals USD -1.69 0 2026-06
ALKERMES USD 0 0.4 2026-06
Alterity Therapeutics Limited AUD 0 0 2025-12
Amgen USD 6.29 1.14 2026-06
Baxter International USD 0.56 0.2 2026-06
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Biogen USD 3.6 0.03 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Cara Therapeutics USD -0.72 0.14 2026-03
Cipla INR 9.76 2.9 2026-06
Dr.Reddys Laboratories INR 5.33 0.47 2026-06
Eisai JPY 64.71 76.24 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Exelixis USD 0.91 0.04 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
Grifols EUR 0.16 0.02 2026-03
Halozyme Therapeutics USD 2.28 0.68 2026-06
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Ironwood Pharmaceuticals USD 0.31 0.07 2026-06
Karyopharm Therapeutics USD -1.02 1.2 2026-03
MacroGenics USD -0.58 0.36 2026-03
Merck USD -0.13 1.15 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06
Pfizer USD 0.77 0.02 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
Takeda JPY 71.65 87.21 2026-06
Teva Pharmaceutical Industries USD 0.06 1.51 2026-06
Xencor USD -0.29 1.42 2026-06